Welcome to the Metabolon Blog!

We post commentary on all things metabolomics – from the latest publications to precision medicine. There are many exciting and growing metabolomics applications, so you never know what will inspire us to start writing. We invite you to subscribe and get each new post directly delivered to your inbox.

An interview with the Co-Founder and CEO of Siolta

Oct 21, 2019, 5:25 AM
We sat down for a conversation with Nikole Kimes, Ph.D., Co-Founder and CEO of Siolta. The company’s name, which is pronounced sheel-ta, is a Gaelic word for “seeds” and speaks to the company’s microbial therapeutics that are created to reseed the depleted gut microbiome with naturally occurring bacteria, which are essential for a healthy immune system.
Read more >

Small Molecules at the Intersection of Health and Microbiota

Oct 4, 2019, 11:24 AM
Metabolon Senior Study Director, Karen DeBalsi, Ph.D., will speak at the 5th Annual European Microbiome Congress. Her seminar titled, “Small Molecules at the Intersection of Health and Microbiota,” will explore how Metabolon’s approach to metabolomics can assess efficacy, monitor toxicity, provide discover biomarkers, measure therapeutic response, determine optimal dosing, gauge non-compliance, and segregate responders from non-responders. The following Q&A from Kiasko Research provides a preview of her upcoming presentation.
Read more >

Metabolomics: A Key to Realizing the Power of ‘Big Data’

Sep 28, 2019, 5:30 AM
Big data initiatives to understand individual health, disease, and therapeutic responses are underway using a wide range of 'omics and clinical assessment tools across a variety of large cohorts in population health studies.
Read more >

Q&A: Approach to frailty population health study with Brent Richards, M.D., M.Sc., Faculty of Medicine at McGill University

Sep 16, 2019, 6:14 AM
We sat down with Brent Richards, M.D., M.Sc., from the Faculty of Medicine at McGill University, to discuss the Canadian population health collaborative study that is aimed at discovering key frailty biomarkers to shed light on why some people become frail, determine the severity of frailty and what can be done to help avoid the condition.
Read more >

The skin microbiome: how metabolomics can advance the next frontier in skin health

Aug 26, 2019, 5:48 AM
What about the microbiome of other body locations, particularly our largest organ – the skin?
Read more >

There is Truth to the Adage “Get Your Beauty Rest”

Aug 6, 2019, 11:41 AM
The fountain of youth is what most people desire as they begin to notice faint lines of wisdom. Factors from a person’s biology or genetics to their environment and lifestyle, including sleep habits, alter metabolite levels affecting the health and appearance of skin. These mechanisms lead to the aging process long before we see the impact on our skin.
Read more >

Obesity – A Massive Problem Impacted by Tiny Things

Jul 22, 2019, 11:25 AM
The prevalence of obesity has increased at a breathtaking rate over the last few decades, with nearly half of the global population estimated to be overweight. This staggering ratio represents a tremendous disease burden since obesity is a major risk factor for many comorbidities, such as cardiovascular disease, fatty liver, and type 2 diabetes. Challenging solutions to address the rise in obesity are complex and not readily isolated to a small collection of genes.
Read more >